Optimal HIV treatment by maximising immune response

Journal of Mathematical Biology

Volumn 48, Issue 5, 2004, Pages 545-562

  Culshaw, Rebecca V ^a   Ruan, Shigui ^b,c   Spiteri, Raymond J ^b  

^a Clarke College   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Department of Biology   (United States)

Author keywords

Cytotoxic lymphocytes; HIV; Immune response; Numerical methods; Optimal control

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ALGORITHM; ARTICLE; BIOLOGICAL MODEL; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DRUG ADMINISTRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; NATURAL KILLER CELL; VIROLOGY;

ALGORITHMS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DRUG ADMINISTRATION SCHEDULE; HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 21244476462     PISSN: 03036812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00285-003-0245-3     Document Type: Article

References (30)

1. Arnaout, R.A., Nowak, M.A., Wodarz, D.: HIV-1 dynamics revisited: biphasic decay by cytotoxic T lymphocyte killing? Proc. Roy. Soc. Lond. B 265, 1347-1354 (2000)
2. Ascher, U.M., Mattheij, R.M.M., Russell, R.D.: Numerical Solution of Boundary Value Problems for Ordinary Differential Equations. Prentice-Hall, Englewood Cliffs, NJ, 1988
3. Ascher, U.M., Spiteri, R.J.: Collocation software for boundary value differential-algebraic equations. SIAM J. Sci. Comput. 15, 938-952 (1994)
4. Carr, A., Emery, S., Kelleher, A., Law, M., Cooper, D.A.: CD8+ lymphocyte responses to antiviral therapy of HIV infection. J. AIDS Hum. Retrovir. 13, 320-326 (1996)
5. Cocchi, F., et al.: Identification of RANTES, MIP-1 alpha, MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T-cells. Sci. 270, 1811-1815 (1995)
6. Culshaw, R.V.: Immune Response Models of HIV Infection and Treatment. Ph.D. thesis, Dalhousie University, 2002
7. Ermentrout, B.: Simulating, Analyzing, and Animating Dynamical Systems: A Guide to XPPAUT for Researchers and Students. SIAM, Philadelphia, 2002
8. Fister, K.R., Lenhart, S., McNally, J.S.: Optimizing chemotherapy in an HIV model. Elect. J. Diff. Eqs. 32, 1-12 (1998)
9. Fleming, W., Rishel, R.: Deterministic and Stochastic Optimal Control. Springer-Verlag, New York, 1975
10. Gray, C.M., Lawrence, J., Schapiro, J.M., Altman, J.D., Winters, M.A., Crompton, M., Loi, M., Kundu, S.K., Davis, M.M., Merigan, T.C.: Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly-active antiretroviral therapy. J. Immunol. 162, 1780-1788 (1999)
11. Haseltine, W.A., Wong-Staal, F.: The molecular biology of the AIDS virus. Scientific American, Oct. 1988, pp. 52-62
12. Keller, H.B.: Numerical Solution of Two-Point Boundary Value Problems. Regional Conference Series in Applied Mathematics, No. 24, SIAM, Philadelphia, 1976
13. Kirschner, D.E., Perelson, A.S.: A model for the immune system response to HIV: AZT treatment studies. In: Arino, O., Axelrod, D., Kimmel, M., Langlais, M. (eds), Mathematical Population Dynamics: Analysis of Heterogeneity. Vol. 1: Theory of Epidemics, Wuerz Pub. Ltd., Winnipeg, Canada, 1995, pp. 295-310
14. Kirschner, D.E., Lenhart, S., Serbin, S.: Optimal control of the chemotherapy of HIV. J. Math. Biol. 35, 775-792 (1997)
15. Kirschner, D.E., Webb, G.: A model for treatment strategy in the chemotherapy of AIDS. Bull. Math. Biol. 58, 167-190 (1996)
16. Kirschner, D.E., Webb, G.: Immunotherapy of HIV-1 Infection. J. Biol. Systems 6, 71-83 (1998)
17. Kirschner, D.E., Webb, G., Cloyd, M.: Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lymphocytes. J. AIDS 24, 352-362 (2000)
18. Klach, A.M.: Lippincott's Nursing Drug Guide 2001. Lippincott, Williams and Wilkins, 2001
19. Murray, J.D.: Mathematical Biology, Springer-Verlag, Berlin-Heidelberg, 1989
20. Musey, L., et al.: Cytotoxic T cell responses, viral load and disease progression in early HIV-type 1 infection. N. Engl. J. Med. 337, 1267-1274 (1997)
21. Nowak, M.A., May, R.M.: Mathematical biology of HIV infections: Antigenic variation and diversity threshold. Math. Biosci. 106, 1-21 (1991)
22. Ogg, G.S., et al.: Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73, 797-800 (1999)
23. Perelson, A.S., Kirschner, D.E., DeBoer, R.: Dynamics of HIV infection of CD4+ T cells. Math. Biosci. 114, 81-125 (1993)
24. Perelson, A.S., Nelson, P.W.: Mathematical analysis of HIV-1 dynamics in vivo. SIAM Rev. 41, 3-44 (1999)
25. Spouge, J.L., Shrager, R.I., Dimitrov, D.S.: HIV-1 infection kinetics in tissue cultures. Math. Biosci. 138, 1-22 (1996)
26. Walker, C.M., Moody, D.T., Stites, D.P., Levy, J.A.: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Sci. 234, 1563-1566 (1986)
27. Weber, J.N., Weiss, R.A.: HIV infection: The cellular picture. Scientific American, Oct. 1988, pp. 101-109
28. Wein, L.M., Zenios, S.A., Nowak, M.A.: Dynamic multidrug therapies for HIV: A control theoretic approach. J. Theor. Biol. 185, 15-29 (1997)
29. Wodarz, D., Klenerman, P., Nowak, M.A.: Dynamics of cytotoxic T-lymphocyte exhaustion. Proc. Roy. Soc. Lond. B 265, 191-203 (1998)
30. Wodarz, D., Nowak, M.: Specific therapies could lead to long-term immunological control of HIV. Proc. Natl. Acad. Sci. 96, 464-469 (1999)